Baby stops seizures with new experimental drug
A baby in Dubai stopped suffering severe seizures after receiving an experimental oral medication for his rare genetic condition.
From birth infant Adnan experienced a fit roughly every thirteen minutes at his local hospital. This medical intervention targeted abnormal activity in a specific ion channel linked to his extremely rare form of genetic epilepsy.
Led by Professor Ubaid Shah, the drug was given on September 14th. Follow up visits on October 11th confirmed he suffered no clinical seizures. He remains seizure free as of November 2nd and is starting to reach important early developmental steps.
Despite this encouraging response, the team will keep watching his health carefully to see if the results last over time. This shows how identifying a genetic cause allows doctors to choose treatments that directly target the disease mechanism.
Researchers stress the medicine needs further study and testing before it can be used openly by the general public. The hospital noted the child is finally showing progress in reaching important early developmental steps.

